• Skip to main content

Diagnosis: Multiple Sclerosis

Coping with multiple sclerosis symptoms, attacks, and treatments

  • Home
  • About
  • Subscribe
  • What Is MS?
  • Gilenya
  • Contact Us

avonex

Diary Of A Gilenya Pioneer: Switching To Gilenya!

February 11, 2011 by Sara

Switching To Gilenya
Gilenya (Fingolimod)

As it turns out, similarly to my father’s results with Avonex, Rebif has caused my liver enzymes to shoot up to about 3X the upper limit of normal in the span of slightly less than 2 years. My options?

1) Tysabri : the risk of PML is too severe for me to brave this drug – reputed to be a risk of death or severe disability as high as 1 in 200 for some individuals and 1 in 2000 for others
2) Copaxone : statistically slightly less effective than interferons – works great for my father but I truly don’t want to do a daily injection except as a last resort
3) Gilenya : aka Fingolimod – when this was approved by the FDA I wrote a blog post to summarize all the information I could find – it is the only oral disease modifying drug for Multiple Sclerosis – DING! DING! DING!

I have chosen to switch to Gilenya.

[Read more…] about Diary Of A Gilenya Pioneer: Switching To Gilenya!

Filed Under: fingolimod, gilenya, insurance, liver damage, lymphocyte, macular edema, multiple sclerosis, rebif, treatment, tysabri Tagged With: avonex, betaseron, copaxone, disease, exacerbation, fingolimod, fty720, gilenya, infection, infusion, injection, interferon, liver, ms, ms attack, multiple sclerosis, neurological disorder, neurologist, novartis, pill, pml, rebif, s1p-receptor modulator, solumedrol, tysabri

Copyright © 2022 · Infinity Pro on Genesis Framework · WordPress · Log in

 

Loading Comments...